中国公众合理用药援助系统
药品查询
请勾选查询条件后检索
药品名 企业名 批准文号 功能主治
你的位置:首页 > 药讯频道 > 药讯 > 学术科研 > 正文
他汀类药物对骨质疏松症的影响研究进展
www.yongyao.net  2008-12-3 17:33:30  来源:  责任编辑:
分享到:

【参考文献】

[ 1 ]  Mundy G,Garrett R ,Harris S ,et al . Stimulation of bone formation invitro and in rodents by statins. Science , 1999 , 286 :194621949.

[ 2 ]  Sugiyama M, Kodama T , Konishi K, et al . Compactin andsimvastatin , but not pravastatin , induce bone morphogenetic protein22in human osteosarcoma cells. Biochem Biophys Res Commun , 2000 ,271 :6882692.

[ 3 ]  Bai Y, Zhang L , Lv ZW, et al . The effect of simvastatin on theosteoblastic differentiation of human bone marrow stromal cells. Chin__ J Osteoporos , 2006 ,13(6) :3812384(in Chinese) .

[ 4 ]  Cai J , Zhang L , YU XQ , et al . Simvastatin promotes osteoblasticdifferentiation of human bone marrow stromal cells. Chin JOsteoporos , 2006 ,12(4) :3972400(in Chinese) .

[ 5 ]  Yu XQ , Zhang L ,Cai J , et al . Effects of simvastatin on Cbfal ,Cbfband Osterix expressions in human bone marrow stromal cells. J FourthMilMed Univ , 2006 ,27 (23) :217522178(in Chinese) .

[ 6 ]  Wilkie D ,Bowman B ,Lyga A , et al . Cerivastatin increases corticalbone formation in OVX rats. J Bone Miner Res ,2000 ,15 :S549.

[ 7 ]  Oxlund H ,dalstra M,Andreassen TT , et al . Statin given perorally toadult rats incteases cancellous bone mass and compressive strength.Calcif Tissue Int ,2001 ,69 :2992304.

[ 8 ]  Skoglund B , Forslund C , Aspenberg P. Simvastatin improvesfracturehealing in mice. J Bone Miner Res ,2002 ,17 :200422008.

[ 9 ]  Serin Kilicoglu S , Erdemli E. New addition to the statinps effect . JTrauma , 2007 ,63 :1872191.

[10 ]  Saraf SK, Singh A , Garbyal RS , et al . Effect of simvastatin onfracture healing ———an experimental study. Indian J Exp Biol ,2007 ,45(5) :4442449.

[11 ]  Adah F , Benghuzzi H , Tucci M, et al . Cholesterol productioninhibitor (statin) increased bone healing in surgically created femoraldefect in an animal model . Biomed Sci Instrum,2007 ,43 :952103.

[12 ]  Skoglund B , Aspenberg P. Locally applied Simvastatin improvesfracture healing in mice. BMC Musculoskelet Disord ,2007 , 8 :98.

[13 ]  Zheng J , Zhang L , Yao SS , et al . Stimulation on osteoblasticdifferentiation in bone marrow stromal cells of rats by simvastatinadministration. Chin J Osteoporos , 2006 , 12 ( 3 ) : 2782282 ( inChinese) .

[14 ]  Yao SS , Zhang L , Zheng J , et al . Effect of simvastatin onosteoblastic differentiation of bone marrow stromal cells in rats. JFourth MilMed Univ , 2006 ,27 (17) :160921612(in Chinese) .

[15 ]  Ye WS , YU SL , Wang BT , et al . Stimulation of bone formation inovariectomized rat by intermittent administration of simvastatin. ChinJ Osteoporos , 2001 ,21(7) :4282432(in Chinese) .

[16 ]  YU SL , Ye WS , Kong DC , et al . Effects of statins andbiophosphonates on femur of ovariectomized rats. Chin J Osteoporos ,2002 ,8 (3) :2432247(in Chinese) .

[17 ]  Liang CY, Zhang L , Zhao WG, et al . Effects of simvastatin femoralfracture healing in rats. J Fourth MilMed Univ , 2006 ,27 (3) :2842286(in Chinese) .

[18 ]  Zhang L , Liu F , Liang CY, et al . Effects of simvastatin femoralfracture healing in ovariectomized rats. J Fourth MilMed Univ , 2007 ,28(15) :137221375(in Chinese) .

[19 ]  Maritz FJ , Conradie MM, Hulley PA , et al . Effect of statins on bonemineral density and bone histomorphometry in rodents. ArteriosclerThromb Vasc Biol , 2001 , 21 : 163621641.

[20 ]  Hughes A , Rogers MJ , Idris AI , et al . A comparison between theeffects of hydrophobic and hydrophilic statins on osteoclast function invitro and ovariectomy2induced bone loss in vivo. Calcif Tissue Int ,2007 , 81 :4032413.

[21 ]  Von Stechow D , Fish S , Yahalom D , et al . Does simvastatinstimulate bone formation in vivo ?BMC Musculoskeled Disord ,2003 ,4 :8.

[22 ]  Tian FM, Zhang L , Meng YQ , et al . Effects of simvastatin on bonemass and the proliferation and differentiation of bone marrow stromalcells in rats. Chin J Osteoporos , 2007 , (13) :5802584(in Chinese) .

[23 ]  Schoofs MW. Sturkenboom MC , van der K1ift M, et al . HMG2CoAreductase inhibitors and the risk of vertebral fracture. J Bone MinerRes ,2004 ,19 :152521530.

[24 ]  Rejnmark L ,Olsen ML ,Johnsen SP ,et al . Hip fracture risk in statinusers2a population2based Danish case2control study. Osteoporos Int ,2004 ,15 :4522458.

[25 ]  Lupattelli G,Scarponi AM,Vaudo G,et al . Simvastatin increases bonemineral density in hypercholesterolemic postmenopausal women. Me2tabolism,2004 ,53 :7442748.

[26 ]  Bauer DC , Sklarin PM, Stone KL , et al . Biochemical markers ofbone turnover and prediction of hip bone loss in older women : thestudy of osteoporotic fractures. J Bone Miner Res ,1999 , 14 : 140421410.

[27 ]  Wang PS , Solomon DH , Mogun H , et al . HMG2CoA reductaseinhibitors and the risk of hip fractures in elderly patients. JAMA ,2000 , 283 : 321123216.

[28 ]  Meier CR , Schlienger RG,Kraenzlin ME , et al . HMG2CoA reductaseinhibitors and the risk of fractures. JAMA ,2000 , 83 : 320523210.

[29 ]  Ray WA ,Daugherty JR , Griffin MR. Lipid2lowering agents and therisk of hip fracture in amedicaid population. Inj Preve ,2002 ,8 (4) :2762279.

[30 ]  Van Staa TP ,Wegman S ,de Vres F ,et al . Use of statins and risk offractures. JAMA ,2001 ,285 :185021855.

[31 ]  Hatzigeorgiou C , Jackson JL. Hydroxymethylglutaryl2coenzyme Areduc2tase inhibitors and osteoporosis : a meta2analysis. OsteoporosInt ,2005 ,16 :9902998.

[32 ]  Solomon DH , Finhelstein JS ,Wang PS , et al . Statin lipid2loweringdrugs and bone mi neral density. Pharmacoepidemiol Drug Saf ,2005 ,14 :2192226.

[33 ]  Montngnani A , Gonnelli S , Cepollaro C , et al . Effect of simvastatintreatment on bone mineral density and bone turnover inhypereholesterolemic postmenopausal women : a 12year longitudinalstudy.Bone ,2003 ,32 :4272433.

[34 ]  Tikiz C ,Unlu Z , Tikiz H , et al . The effect of simvsatatin on serumcytokine levels and bone metabolism in postmenopausal subjects :negative correlation between TNF2alpha and anabolic boneparameters. J Bone Miner Metab ,2004 ,22 :3652371.

[35 ]  Pasco JA , Kotowicz MA , Henry MJ , et al . Statin use , bone mineraldesity, and fracture risk : Geelong Osteoporosis Study. Arch InternMed , 2002 ,162 :5372540.

免责声明:本文仅代表作者个人观点,与本网无关。转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责。对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不作任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
返回资讯中心 返回资讯列表